Cargando…

HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products

The objective of the present study was to investigate the role of high-mobility group box-1 (HMGB1) in the seizure-induced P-glycoprotein (P-gp) overexpression and the underlying mechanism. Kainic acid (KA)-induced mouse seizure model was used for in vivo experiments. Male C57BL/6 mice were divided...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yan, Huang, Xian-Jing, Yu, Nian, Xie, Yuan, Zhang, Kang, Wen, Fang, Liu, Hao, Di, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613137/ https://www.ncbi.nlm.nih.gov/pubmed/26485677 http://dx.doi.org/10.1371/journal.pone.0140918

Ejemplares similares

Evidence for Activation of Toll-Like Receptor and Receptor for Advanced Glycation End Products in Preterm Birth
por: Noguchi, Taketoshi, et al.
Publicado: (2010)

Advanced Glycation End Products and Activation of Toll-like Receptor-2 and -4 Induced Changes in Aquaporin-3 Expression in Mouse Keratinocytes
por: Luo, Yonghong, et al.
Publicado: (2023)

Receptor for Advanced Glycation End Products Regulates Adipocyte Hypertrophy and Insulin Sensitivity in Mice: Involvement of Toll-Like Receptor 2
por: Monden, Masayo, et al.
Publicado: (2013)

Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products
por: Chen, Ying Ju, et al.
Publicado: (2013)

High-Mobility Group Box 1 Inhibits Gastric Ulcer Healing through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products
por: Nadatani, Yuji, et al.
Publicado: (2013)

The Receptor for Advanced Glycation End Products (RAGE) Contributes to the Progression of Emphysema in Mice
por: Sambamurthy, Nisha, et al.
Publicado: (2015)

Contributions of the receptor for advanced glycation end products axis activation in gastric cancer
por: Rojas, Armando, et al.
Publicado: (2023)

High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4
por: Wang, Chen, et al.
Publicado: (2015)

HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
por: Ren, Wenxuan, et al.
Publicado: (2023)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

HMGB1 is an early mediator of inflammation and may be negatively regulated by soluble receptor for advanced glycation end products in experimental endotoxinemia and in sepsis
por: Sunden-Cullberg, Jonas, et al.
Publicado: (2008)

Expression and Significance of High-Mobility Group Protein B1 (HMGB1) and the Receptor for Advanced Glycation End-Product (RAGE) in Knee Osteoarthritis
por: Sun, Xue-Hui, et al.
Publicado: (2016)

HMGB-1 induces c-kit(+) cell microvascular rolling and adhesion via both toll-like receptor-2 and toll-like receptor-4 of endothelial cells
por: Furlani, Dario, et al.
Publicado: (2012)

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
por: Chen, Jinluan, et al.
Publicado: (2021)

Advanced glycation end products regulate the receptor of AGEs epigenetically
por: Wu, Xiaoqing, et al.
Publicado: (2023)

Imaging receptor for advanced glycation end product expression in mouse model of hind limb ischemia
por: Tekabe, Yared, et al.
Publicado: (2013)

Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice
por: Chatterjee, Piyali, et al.
Publicado: (2012)

Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
por: Yue, Qing, et al.
Publicado: (2022)

Receptor for advanced glycation end products axis in critically ill patients
por: Ingels, C, et al.
Publicado: (2014)

Soluble receptor for advanced glycation end-products and progression of airway disease
por: Iwamoto, Hiroshi, et al.
Publicado: (2014)

The receptor for advanced glycation end products in ventilator-induced lung injury
por: Kuipers, Maria T, et al.
Publicado: (2014)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
por: Chuah, Yaw Kuang, et al.
Publicado: (2013)

Targeted nanoparticles for multimodal imaging of the receptor for advanced glycation end-products
por: Drake, Lindsey R., et al.
Publicado: (2018)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
por: Taneja, Sakshi, et al.
Publicado: (2021)

Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients
por: Lazzari, Tássia Kirchmann, et al.
Publicado: (2021)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
por: Li, Jia-Yi, et al.
Publicado: (2017)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
por: Mersmann, Jan, et al.
Publicado: (2013)

Sulfatide Inhibits HMGB1 Secretion by Hindering Toll-Like Receptor 4 Localization Within Lipid Rafts
por: Kim, Hee Sue, et al.
Publicado: (2020)

Toll-Like Receptors Signaling Contributes to Immunopathogenesis of HBV Infection
por: Kondo, Yasuteru, et al.
Publicado: (2011)

Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease
por: Wong, Foo Nian, et al.
Publicado: (2016)

Echinacoside-Zinc Nanomaterial Inhibits Skin Glycation by Suppressing the Transcriptional Activation of the Receptor for Advanced Glycation End-Products
por: Han, Jingxia, et al.
Publicado: (2023)

Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
por: Li, Lingzhao, et al.
Publicado: (2022)

Do advanced glycation end products contribute to food allergy?
por: Smith, P. K., et al.
Publicado: (2023)

The Role of the Receptor for Advanced Glycation End-Products in a Murine Model of Silicosis
por: Ramsgaard, Lasse, et al.
Publicado: (2010)

The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
por: Yaser, Al-Madhagi, et al.
Publicado: (2012)

Advanced Glycation End-Products and Their Receptor-Mediated Roles: Inflammation and Oxidative Stress
por: Younessi, Parisa, et al.
Publicado: (2011)

The myeloid response to pancreatic carcinogenesis is regulated by the receptor for advanced glycation end-products
por: Vernon, Philip J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0staf5brbmn2nqea3gcukeqlbn